What are Shrooms (Magic Mushrooms)?
“Shrooms” or “magic mushrooms” are fungi that contain the psychoactive compounds psilocybin and psilocin. These naturally occurring psychedelics produce altered perception, mood, and cognition when ingested. There are over 200 species of psilocybin-containing mushrooms, with Psilocybe cubensis being the most common.
Active Compounds:
| Compound | Role |
|---|---|
| Psilocybin | Prodrug (converted to psilocin in the body) |
| Psilocin | Active psychedelic compound |
Common Street Names:
-
Shrooms
-
Magic mushrooms
-
Boomers
-
Liberty caps (Psilocybe semilanceata)
-
Golden tops (Psilocybe cubensis)
-
Philosopher’s stones (truffles, sclerotia)
-
Mushies
Medical Research Status (Educational):
Unlike cocaine, heroin, or methamphetamine, psilocybin is currently being studied in clinical trials for various mental health conditions, including:
-
Treatment-resistant depression
-
End-of-life anxiety (cancer patients)
-
Substance use disorders (alcohol, tobacco, opioids)
-
Obsessive-compulsive disorder (OCD)
-
Cluster headaches
IMPORTANT: Despite promising research, psilocybin remains a Schedule I controlled substance in the US and a Class A drug in the UK. It is not approved for medical use outside of specific clinical trials or regulated programs (e.g., Oregon’s psilocybin therapy program, which is legally restricted).
“Shrooms” in Recreational Context:
When used recreationally (illegally), users may experience:
| Effect | Description |
|---|---|
| Visual hallucinations | Flowing colors, geometric patterns, tracers |
| Altered time perception | Minutes feel like hours |
| Euphoria or dysphoria | Intense happiness or fear/anxiety |
| Introspection | Deep thoughts about self and life |
| Synesthesia | “Seeing” sounds or “hearing” colors |
| Spiritual or mystical experiences | Sense of connection to something greater |
Physical Effects of Shrooms:
-
Dilated pupils
-
Increased heart rate and blood pressure
-
Nausea and vomiting (especially with raw mushrooms)
-
Yawning and tearing
-
Tremors or muscle weakness
-
Dizziness and lightheadedness
-
Loss of coordination (ataxia)
-
Increased body temperature (hyperthermia)
Routes of Administration:
| Method | Description | Onset | Duration |
|---|---|---|---|
| Oral (chewed/swallowed) | Raw or dried mushrooms | 20-60 minutes | 4-6 hours |
| Tea | Brewed in hot water | 15-30 minutes | 3-5 hours |
| Lemon tek | Soaked in lemon juice (enhances conversion) | 15-30 minutes | 3-4 hours |
| Edibles | Mixed into chocolate, food, or gummies | 20-60 minutes | 4-6 hours |
Dosage Guide (Educational Only — Not a Recommendation):
| Dose (dried psilocybe cubensis) | Effect Level |
|---|---|
| 0.5 – 1.0 grams | Mild (mood lift, slight visual changes) |
| 1.0 – 2.5 grams | Moderate (visuals, altered thinking, euphoria) |
| 2.5 – 4.0 grams | Strong (intense visuals, ego dissolution possible) |
| 4.0+ grams | Heavy (profound mystical experience, loss of reality contact) |
⚠️ Potency varies widely by species, batch, and individual mushrooms — even from the same source.
Immediate Risks (“Bad Trips”):
-
Severe anxiety and panic
-
Paranoia and fear of losing control
-
Confusion and disorientation
-
Agitation and aggressive behavior
-
Frightening hallucinations (monsters, demons, death)
-
Self-harm or harm to others (during psychotic-like state)
Serious Adverse Effects:
| Risk | Description |
|---|---|
| Psychosis | Especially in individuals with personal/family history of schizophrenia or bipolar disorder |
| Hallucinogen Persisting Perception Disorder (HPPD) | Flashbacks lasting weeks, months, or years after use |
| Accidents/injury | Falling, drowning, walking into traffic during altered state |
| Suicide attempt | Severe bad trips can lead to self-harm |
| Serotonin syndrome | Rare, but possible with other serotonergic drugs |
Can You Overdose on Shrooms?
| Question | Answer |
|---|---|
| Fatal overdose from psilocybin alone | Extremely rare (would require massive quantity, >1000x normal dose) |
| Death from behavior during trip | Yes (accidents, suicide, dangerous behavior) |
| Death from adulterated product | Possible (shrooms laced with fentanyl, other drugs) |
| Toxic syndrome (toxidrome) | Uncommon; but nausea, vomiting, and agitation are common |
Signs of a Psilocybin Emergency:
-
Extreme agitation or violence
-
Self-harm or suicidal statements
-
Persistent vomiting or severe nausea
-
Seizures
-
Hyperthermia (dangerously high body temperature)
-
Loss of consciousness
-
Inability to be calmed or redirected
Emergency Response for a “Bad Trip” or Overdose:
| Do This | Avoid This |
|---|---|
| Stay calm and speak softly | Panic or yell |
| Move to a quiet, low-stimulation environment | Take to a crowded or loud place |
| Reassure the person (“this will pass,” “you’re safe”) | Argue or challenge their perceptions |
| Offer water (if conscious and able to swallow) | Force anything by mouth |
| Call 911 if danger to self/others or medical emergency | Leave them alone |
| If unknown substance (possible fentanyl), administer naloxone | Assume it’s “just mushrooms” |
Drug Interactions:
| Drug Class | Interaction | Risk |
|---|---|---|
| SSRIs (antidepressants) | Reduced psilocybin effects; possible serotonin syndrome | Low to moderate |
| MAO inhibitors | Significantly increased potency; dangerous interaction | High |
| Lithium | Increased risk of seizures | Moderate |
| Alcohol | Increased nausea, confusion, poor judgment | Moderate |
| Other psychedelics (LSD, MDMA) | Intensified effects, prolonged duration | Moderate |
Pregnancy and Breastfeeding:
-
Pregnancy: No human studies. Psilocybin crosses the placenta. Not recommended.
-
Breastfeeding: Psilocin passes into breast milk. Not recommended. No safe dose established.
Legal Status (By Jurisdiction):
| Country/Region | Classification | Notes |
|---|---|---|
| United States (federal) | Schedule I | Illegal; no accepted medical use (federally) |
| Oregon (state) | Legal for regulated therapeutic use | Psilocybin therapy program (licensed facilitators only) |
| Colorado (state) | Decriminalized + regulated therapy | Personal use decriminalized; therapy centers coming |
| Canada | Schedule III | Illegal (exceptions for clinical trials) |
| United Kingdom | Class A | Illegal; maximum 7 years imprisonment for possession |
| Netherlands | Legal (truffles, not mushrooms) | Fresh mushrooms banned; sclerotia (truffles) legal |
| Jamaica | Legal | No specific laws against psilocybin |
| Brazil | Legal (for religious use) | Religious exemptions for ayahuasca/uniao do vegetal |
Tolerance and Dependence:
| Property | Assessment |
|---|---|
| Physical dependence | None (no withdrawal syndrome) |
| Psychological dependence | Low to moderate (rare compared to other drugs) |
| Tolerance | Rapidly builds after single use; returns to baseline after 5-14 days |
| Cross-tolerance | Yes — with LSD, mescaline, other psychedelics |
Withdrawal Symptoms:
Psilocybin does not cause a classic withdrawal syndrome. However, psychological after-effects may include:
-
Fatigue
-
Mood swings
-
Flashbacks (HPPD)
-
Depersonalization or derealization (rare)
Long-Term Effects of Frequent Use:
| Effect | Frequency |
|---|---|
| HPPD (flashbacks) | Rare (estimated <5% of users) |
| Persistent psychosis | Very rare (almost always in predisposed individuals) |
| Cognitive impairment | Unclear; some studies show no lasting deficits |
| Personality changes | Possible (increased openness often reported) |
Current Clinical Research (Educational Context):
| Condition | Research Phase | Key Finding |
|---|---|---|
| Treatment-resistant depression | Phase II/III | Significant, rapid antidepressant effects |
| End-of-life anxiety | Phase II | Reduces anxiety and depression in cancer patients |
| Alcohol use disorder | Phase II | Reduces heavy drinking days |
| Smoking cessation | Phase II | 80% abstinence at 6 months (small study) |
| OCD | Phase I/II | Symptom reduction |
Oregon Psilocybin Therapy Program (Educational Example):
| Feature | Requirement |
|---|---|
| Legal status | Legal (since 2023) |
| Setting | Licensed service center only |
| Facilitator | Licensed, trained psilocybin facilitator |
| Prescription | Not required (but screening required) |
| Personal use | Illegal (only supervised sessions) |
| Take-home product | Not permitted |
Harm Reduction Information (Educational Only):
For individuals who choose to use despite legal and health risks:
| Recommendation | Rationale |
|---|---|
| Have a sober “trip sitter” | Someone to help if panic or emergency occurs |
| Use in a safe, calm environment | Familiar space reduces anxiety |
| Start with low dose (0.5-1g dried) | Potency varies; better to underdose than overdose |
| Do not use alone | Accidents or psychological emergency can occur |
| Avoid if personal/family history of psychosis or schizophrenia | Risk of triggering long-term psychosis |
| Do not drive or operate machinery for 8-12 hours | Impaired judgment, perception, coordination |
| Stay hydrated (but not overhydrated) | Nausea and sweating can cause dehydration |
| Avoid mixing with alcohol or other drugs | Increases confusion, nausea, and risk |
| If fear or panic occurs, change environment or music | Calming music, low light, reassurance |
| Call for medical help if agitation, violence, or loss of consciousness | Do not assume it will “pass” |
Where to Get Help for Substance Use or Mental Health Emergency:
| Resource | Contact | Purpose |
|---|---|---|
| Poison Control (US) | 1-800-222-1222 | Overdose guidance |
| 911 / Emergency | 911 | Life-threatening emergency (agitation, seizures, unconsciousness) |
| SAMHSA Helpline (US) | 1-800-662-4357 | Substance use support, 24/7 confidential |
| Fireside Project (psychedelic support line) | 6-2FIRESIDE (623-473-7433) | Peer support for bad trips, integration |
Key Educational Message:
Magic mushrooms (psilocybin) are powerful psychedelics that are being studied for mental health treatment. However, outside of regulated clinical trials or legal frameworks (e.g., Oregon), they remain illegal and unregulated. Unsupervised use carries risks of bad trips, psychosis (especially in predisposed individuals), accidents, and HPPD. Counterfeit products may contain other dangerous drugs. If you choose to use despite these risks, harm reduction strategies can reduce but not eliminate danger.




